 Clinical disease drug susceptibility biochemical patterns unnamed third biovariant complex Mycobacterium fortuitum Previous studies Mycobacterium fortuitum isolates biovariants Eighty-five clinical isolates group third biovariant complex isolates fortuitum Texas laboratory isolates Queensland Australia infections skin soft tissue bone metal puncture open fractures Isolates biovar fortuitum resistance acid use mannitol inositol carbon sources subgroups present examples American Type Culture Collection Isolates resistant one-third resistant susceptible ciprofloxacin sulfamethoxazole imipenem Surgical debridement drug therapy vitro susceptibilities cures cutaneous disease osteomyelitis DNA homology studies taxonomic status organisms